SCHEMBL6985796

SCHEMBL6985796

CC1OCC(=O)C1(C)NC(=O)C(C(N)=O)c1ccc(O)cc1

nearest known ligand 0.33

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.33
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KDM4E B2RXH2 3/20 0.31
LMNA P02545 1/20 0.31
RARB P10826 1/20 0.31
RARG P13631 1/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
NR1I3 Q14994 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749636 0.79 SLC7A5 (0.42)
SCHEMBL6987871 0.74 CTSK (0.39) KDM4ELMNA
SCHEMBL6988403 0.73 KMT2A (0.35) TDP1KDM4ELMNA
SCHEMBL6747731 0.73 CTSL (0.42)
SCHEMBL6988433 0.71 TAS1R3 (0.35)
SCHEMBL6749612 0.70 LARS1 (0.34)
SCHEMBL6982132 0.70 TAOK1 (0.36) KDM4ELMNA
SCHEMBL6988397 0.70 CTSL (0.43)
SCHEMBL6981853 0.70 TRPV1 (0.42)
SCHEMBL6747644 0.69 CTSL (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed